E-drug: Table of content Prescrire International, June 2000
---------------------------------------------
Table of contents of Prescrire International, June 2000 - Volume 9 =96 Nr. 47
Prescrire International is the English language edition of La revue
Prescrire. It consists of a selection of articles of international
interest from the monthly French-language journal La revue Prescrire. Prescrire International contains evaluations of new drugs and new indications, information on adverse effects, and assessments of therapeutic interventions.
Editorial
Prosperous drug companies 66
New Products
Abacavir (new preparation) 67
Potentially severe hypersensitivity reactions
Alendronic acid in primary prevention (new indication) 70
Uncertain benefit, major constraints
Ribavirin (new preparation) 72
Offers an advantage in combination with interferon alfa-2b
Goserelin and locally advanced prostate cancer (new indication) 75 Survival benefit offset by endocrine and urinary reactions
Lidocaine + prilocaine before 3 months (new indication) 77
Possibly helpful for preventing painful procedures
Adverse Effects
Dexamethasone misused for weight gain 80
Irrational drug use in Morocco
Bronchospasm with zanamivir 80
Especially in patients with asthma and chronic bronchitis
Reviews
Antiplatelet drugs in cardiovascular prevention 81
Risk-benefit ratios of antiplatelet drugs in coronary disease, stroke, atrial fibrillation, and primary cardiovascular prevention
Prevention of mother-child HIV transmission 92
About zidovudine, nevirapine, multidrug regimens and caesarean section
Prescrire International is financed by subscription fees only. We cannot provide free subscriptions. If you do not know the journal we can send you a sample issue. Send us your name and address if you want to receive a sample issue of Prescrire International. An annual subscription covers six issues of Prescrire International plus an index to issues during the previous five years and costs $ 60 (FF 310) for individuals, $38 (FF 200) for students, and 240$ (FF1240) for commercial institutions.
La revue Prescrire
BP 459
75527 Paris Cedex 11
France
Tel. 33 1 49 23 72 63
Fax 33 1 48 07 87 32
Email : international@prescrire.org
--
Send mail for the `E-Drug' conference to `e-drug@usa.healthnet.org'.
Mail administrative requests to `majordomo@usa.healthnet.org'.
For additional assistance, send mail to: `owner-e-drug@usa.healthnet.org'.